Clinical Trials Sponsored by PneumRx, Inc.

Total 35374 results

Boston Scientific Corporation
PneumRx, Inc.

Completed

Evaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema

Emphysema

Germany, Netherlands
Boston Scientific Corporation
PneumRx, Inc.

Terminated

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009) (CROSSOVER)

Emphysema

United States, Netherlands, France, Canada, United Kingdom
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Post Market Observational, Prospective, Multi-center Study

Emphysema

United Kingdom, Spain, Germany, Switzerland, Austria, Denmark
CHU de Reims
PneumRx, Inc.

Unknown

Lung Volume Reduction Coil Treatment in Emphysema. (STICREVOLENS)

Emphysema

France
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study (RENEW)

Emphysema

United States, Netherlands, France, Canada, Germany, United Kingdom
Boston Scientific Corporation
PneumRx, Inc.

Completed

Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema

Emphysema

Netherlands
Boston Scientific Corporation
PneumRx, Inc.

Completed

Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema (ELEVATE)

Emphysema

United Kingdom, France, Germany, Netherlands, Italy, Austria
Boston Scientific Corporation
PneumRx, Inc.

Completed

Randomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)

Emphysema

United Kingdom
Boston Scientific Corporation
PneumRx, Inc.

Completed

Feasibility Study of PneumRx's Lung Volume Reduction Coil (LVRC)

Emphysema

Netherlands, Germany, France
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Changes in Lung Physiology and Cardiac Performance in Patients With Emphysema Post Bilateral RePneu Coil Treatment

Emphysema

Germany
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Chronic Obstructive Pulmonary Disease (COPD) Co-Pilot AIR Substudy of CLN0014 (Co-Pilot Air)

COPD Symptoms After Coil Procedure

Switzerland
HGE Health Care Solutions, LLC
PneumRx, Inc.

Unknown

Evaluation of COPD Co-Pilot

Pulmonary Disease, Chronic Obstructive

United States
HGE Health Care Solutions, LLC
PneumRx, Inc.

Unknown

Evaluation of COPD Co-Pilot

COPD

United States
Pneuma Respiratory, Inc

Completed

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD

COPD

United States
Institut für Pneumologie Hagen Ambrock eV
PneumRx, Inc.

Completed

Improvement of Sleep Quality by RePneu® Coils in Advanced Pulmonary Emphysema

Emphysema | COPD

Germany
Pneuma Pharmaceuticals Incorporated

Terminated

Calfactant for Direct Acute Respiratory Distress Syndrome (CARDS)

Respiratory Distress Syndrome, Adult

Korea, Republic of, United States, Canada, New Zealand, Australia, Israel
Groupe Francais De Pneumo-Cancerologie

Recruiting

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion (RESAMEX)

Non-small Cell Lung Cancer | EGFR Exon 20 Insertion Mutation

France
Groupe Francais De Pneumo-Cancerologie

Completed

Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression. (EXPLORE-PDL1)

Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie

Completed

Feasibility of re Biopsies at Progression (GFPC-REBIOP)

Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie

Completed

Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) (EPNEC)

Large Cell Lung Cancer | Neuroendocrine Carcinoma of Lung (Diagnosis)

France
Groupe Francais De Pneumo-Cancerologie

Completed

Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) (EGFR-RETRO)

NSCLC Non Small Cells Lung Cancer

France
Michael Wilson & Associates Health Care Consulting...
Pneumex Corporation

Terminated

Low Back Study to Compare Traditional Physical Therapy With Combined Therapy Protocol

Low Back Pain | Radiculopathy

United States
Groupe Francais De Pneumo-Cancerologie

Completed

Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer (OPERAGE)

Carcinoma, Non-Small-Cell Lung

France
Groupe Francais De Pneumo-Cancerologie

Completed

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie
AstraZeneca

Active, not recruiting

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE) (OBSTINATE)

Non-Small Cell Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie
Takeda

Recruiting

Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC (BIOEXALK)

Non-small Cell Lung Cancer | ALK Gene Rearrangement Positive

France
Groupe Francais De Pneumo-Cancerologie
Bristol-Myers Squibb

Active, not recruiting

Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) (MESO-IMMUNE)

Malignant Pleural Mesothelioma | Unresectable Malignant Neoplasm

France
University Hospital, Limoges
Groupe Francais De Pneumo-Cancerologie

Completed

Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

France
University Hospital, Brest
Groupe Francais De Pneumo-Cancerologie

Recruiting

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 % (PERSEE)

Non-small-cell Lung Cancer

France
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Centre Hospitalier Intercommunal Creteil
Groupe Francais De Pneumo-Cancerologie

Terminated

Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases (METAL2)

Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Cerebral Metastases | Adenocarcinoma of Lung Metastatic to Brain

France
Groupe Francais De Pneumo-Cancerologie
Sanofi; Chugai Pharma USA

Completed

Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie
Baxter Healthcare Corporation; Amgen

Unknown

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

France
Centre Francois Baclesse
Hoffmann-La Roche; Groupe Francais De Pneumo-Cancerologie

Terminated

A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR (FLARE)

NSCLC Patients With EGFR Activating Mutation

France
Intergroupe Francophone de Cancerologie Thoracique
Groupe Francais De Pneumo-Cancerologie

Completed

Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer

Advanced Non Small Cell Lung Cancer

France
Intergroupe Francophone de Cancerologie Thoracique
PharmaMar; Groupe Francais De Pneumo-Cancerologie

Completed

RW Effectiveness of Lurbinectedin in Extensive Stage SCLC (LURBICLIN)

Small-cell Lung Cancer

France
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Intergroupe Francophone de Cancerologie Thoracique
University Hospital, Caen; Groupe Francais De Pneumo-Cancerologie

Completed

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study (MAPS)

Mesothelioma

France
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
University Hospital, Brest
Roche Farma, S.A; Pierre Fabre Medicament; Groupe Francais De Pneumo-Cancerologie

Completed

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer (VinMetAtezo)

Non-small Cell Lung Cancer

France
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico

Clinical Trials Sponsored by PneumRx, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations